GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CareDx Inc (FRA:1K9) » Definitions » Institutional Ownership

CareDx (FRA:1K9) Institutional Ownership : 79.78% (As of Jun. 10, 2024)


View and export this data going back to 2018. Start your Free Trial

What is CareDx Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, CareDx's institutional ownership is 79.78%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, CareDx's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, CareDx's Float Percentage Of Total Shares Outstanding is 75.17%.


CareDx Institutional Ownership Historical Data

The historical data trend for CareDx's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareDx Institutional Ownership Chart

CareDx Historical Data

The historical data trend for CareDx can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 78.59 78.45 74.92 77.69 80.82 78.12 78.66 81.20 80.13 79.78

CareDx Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


CareDx (FRA:1K9) Business Description

Traded in Other Exchanges
Address
8000 Marina Boulevard, Brisbane, CA, USA, 94005
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden.

CareDx (FRA:1K9) Headlines

No Headlines